June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Measurement of ocular rigidity in patients undergoing intravitreal anti-VEGF injections
Author Affiliations & Notes
  • Jocelyn G Lam
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Ian Luttrell
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Kasra Rezaei
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Jennifer R Chao
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Yewlin Chee
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Leona Ding
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Joanne C Wen
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Footnotes
    Commercial Relationships   Jocelyn Lam, None; Ian Luttrell, None; Kasra Rezaei, None; Jennifer Chao, None; Yewlin Chee, None; Leona Ding, None; Joanne Wen, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 3137. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Jocelyn G Lam, Ian Luttrell, Kasra Rezaei, Jennifer R Chao, Yewlin Chee, Leona Ding, Joanne C Wen; Measurement of ocular rigidity in patients undergoing intravitreal anti-VEGF injections. Invest. Ophthalmol. Vis. Sci. 2017;58(8):3137.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Studies have suggested that ocular rigidity (OR) may play a role in the biomechanics and pathogenesis of glaucoma. However, the effect of ocular rigidity is not well understood and its utility remains limited in current clinical practice. Anti-VEGF injections are known to cause a transient elevation in intraocular pressure (IOP) due to the limited compliance of the eye. Whether these repeated IOP elevations lead to changes in OR is unknown. We measured OR in patients undergoing anti-VEGF injections and other variables to determine whether any correlated with an increased post-injection IOP elevation.

Methods : We conducted a pilot study of patients who underwent intravitreal anti-VEGF injection. Patients with a history of glaucoma, ocular hypertension, current use of IOP lowering medications, and ocular surgery other than cataract extraction were excluded. Patients undergoing bilateral injections were also excluded. Baseline characteristics, axial length, pachymetry, and corneal hysteresis values were recorded. The coefficients of ocular rigidity values were obtained in injected and fellow non-injected eyes via Schiøtz tonometry and use of a standard conversion table.

Results : Nineteen eligible subjects were included in the analysis. Mean age was 64.1 ± 13.8 years, 47% (9/19) were female, 53% (10/19) had a diagnosis of diabetic macular edema and 74% of injected medication (14/19) was aflibercept. Range of total injections was 1-46 (mean = 11). Post-injection IOP was significantly increased compared to baseline IOP following injection of anti-VEGF (mean change in IOP = 29.0 ± 9.5 mmHg; p<0.001). No correlation was found between the total number of injections and the coefficient of OR (r = -0.284; p=0.25). Increasing corneal hysteresis significantly correlated with a larger change in IOP following intravitreal injection (r = 0.62, p = 0.04), while coefficient of OR, axial length and corneal thickness did not.

Conclusions : Intravitreal injection of anti-VEGF compound leads to a significant transient rise in IOP following injection. The coefficient of OR was not significantly correlated with total number of anti-VEGF injections. However, increasing corneal hysteresis was correlated with increased change in post-injection IOP.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×